[QUOTE=+A465B;178096]Medical care costs in US are sky high out of control. If one takes the time to understand that medical care EATS about 17% of US GDP — the scale of the problem is evident. ALL federal spending for everything is only about 21-23% of GDP, and a lot of that is recycled into roadworks, infrastructure, defense, parks and indeed social support.
So medical costs are a serious big problem. Maybe not for you today, but yes, for all of us at some point in time. 25% of senior citizens bankrupted by medical costs? What a tragedy for good upstanding people. What a national disgrace. Premiums don’t go up because there is Obamacare. Premiums go up - even with an actuarially sound population group enrolled - because medical costs go up. Just the facts. Our insurance in the USA would not even be available to us except for Obamacare, since on a commercial, medically underwritten basis, no one would want the risk. Maybe a past cancer? A little diabetes? You’re 50 years old with a touch of high blood pressure? Sorry, move along there matey, we’ll not have you in our group… why not pay $4,000 a night for a hospital room on your own tab. Then you’ll feel the part about harming a segment of the population.
Thimk about it.[/QUOTE]
What I want to know is if the medical care industry in say France or Denmark made up of “FOR PROFIT” commercial businesses or socialized “NOT FOR PROFIT” government owned enterprise? I believe one of the very worst factors that makes the medical care in the USA so high priced is that so many businesses is allowed to extract high profits. Hospitals, doctors, pharmaceutical companies. insurers, medical device makers all have no regulation which says their services which is a vital one to a populace and thus that their profits be limited to keep costs reasonable for the PEOPLE!
PROFIT MAKING HEALTHCARE LIKE IN THE USA IS THE REAL DISGRACE!
[B]Pharmaceutical Company CEO Defends 5,000% Price Hike of Drug on Twitter[/B]
By Olivia Becker
September 21, 2015
The 32-year-old CEO and founder of a pharmaceutical startup took to Twitter to staunchly defend himself from a barrage of criticism after it was revealed that his company had raised the price of a common medication by 5,000 percent.
Immediately after Turing Pharmaceuticals acquired the rights to the drug Daraprim, a common anti-parasitic drug that is used to prevent malaria and fight infections like toxoplasmosis that can arise from AIDS and cancer, the company hiked the price up from $13.50 to $750 per pill. The company and its CEO Martin Shkreli quickly became the subject of a furious backlash.
Shkreli not only seemed unbothered by the outcry, he appears to be actively enjoying the attention online. Take his reply to one exchange in which he was asked how he manages to sleep at night:
In another response, Shkreli said it was not his fault if people who needed the drug could no longer afford it. He also quoted a lyric from the rapper Eminem about his feelings toward the media. He tweeted more than 125 responses to people calling him out online on Monday after the price increase gained traction over the weekend, noted Tech Crunch, but later deleted many of them.
Shkreli also defended his company’s price hike on Bloomberg TV on Monday, insisting that his company “needed to turn a profit on the drug” despite the pill costing less than a dollar to manufacture.
“Its still underpriced compared to its peers,” Shkreli added.
A former hedge-fund manager, Shkreli has come under scrutiny in the past for accusations that he attempted to illegally manipulate the prices of drugs made by companies whose stock he was shorting.
